Breast Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of breast cancer and rising product developmental activities across the globe

The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030. The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and the availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market Dynamics:

According to Globocan 2024, it stated that globally 2,296,840 were affected by breast cancer. Furthermore, the same source stated that Asia accounted for 985,817 breast cancer cases, Europe accounted for 557,532 breast cancer cases, and Africa accounted for 198,553 breast cancer cases. The high global incidence of breast cancer is driving demand for breast reconstruction options, including implants, as many patients seek reconstructive surgery post-mastectomy. This trend is expanding the market for breast implants, supporting physical and emotional recovery for survivors.

Various product developmental activities by the key market players will further boost the market for the same. For instance, in September 2024, GC Aesthetics(R) (GCA), a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, announced the launch of the YOUTHLY(TM) brand in China, featuring its latest breast implant innovations; PERLE(TM), Luna XT(TM), and the latest version of The Round Collection(TM), 100% filled.

Additionally, in August 2024, CollPlant and Stratasys announced the pre-clinical study for regenerative breast implants with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer.

Hence, the interplay of all the above-mentioned factors is expected to drive the breast implant market during the given forecast period from 2024 to 2030.

However, the potential risks associated with breast implants, the high cost associated with breast augmentation procedures, and others may restrict the market growth for the breast implants market.

Breast Implants Market Segment Analysis:

Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the breast implants market, saline breast implants are anticipated to hold a significant market share in the year 2023. This is due to various features associated with saline breast implants.

Saline implants are generally considered safer in cases of rupture, as the body can absorb the saline solution without adverse effects. This safety advantage is particularly important in markets where stringent regulatory standards prioritize patient safety, contributing to higher adoption rates.

Additionally, saline implants require a smaller incision for insertion, as they are filled after placement, which appeals to patients seeking minimally invasive procedures with reduced scarring. Furthermore, advancements in saline implant design, such as improved shell technology and adjustable volume options, have enhanced their durability, aesthetic outcomes, and customization, making them an attractive option for both patients and surgeons.

Additionally, in May 2024, Bimini Health Tech assembled a comprehensive portfolio incorporating the Serene structured saline breast implant, an Acellular Dermal Matrix (ADM), and the Puregraft family of fat transfer products.

Therefore, the widespread uses and various advantages of saline breast implant that enhance performance and usability, solidifying a significant impact on the growth of the overall breast implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall breast implant market:

Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, acting as key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.

According to the American Society of Plastic Surgeons 2024, it stated that in 2022, there were about 304,181 breast augmentation procedures in the US. The same source further stated that about 157,740 breast reconstruction procedures happened in the year 2022. Thus, the growing number of breast cosmetic surgeries and reconstruction procedures is anticipated to surge the demand for breast implants in the region, thereby propelling the market for the same.

As per data from Globocan 2024, it stated that in the year 2022, 274,375 people in the US and 31,823 people in Canada were affected by breast cancer. The high incidence of breast cancer in the region is driving the demand for breast implants, as many patients seek reconstructive surgery post-treatment. This trend highlights a growing market for breast implants, with a focus on supporting patients' recovery and body confidence.

Various product developmental strategies by key players in the region play a major role in pushing forward the revenue shares of breast implants in the region. For example, in October 2021, AbbVie, a manufacturer of breast implants launched a breast cancer campaign to highlight reconstruction options among women. Moreover, product launches by key market players in the region is further expected to propel the growth of the North America breast implants market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market key players:

Some of the key market players operating in the breast implants market include Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

Recent Developmental Activities in the Breast Implants Market:

• In September 2024, Establishment Labs announced the US Food and Drug Administration (FDA) approval for its Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants.
• In April 2024, GC Aesthetics, a leading designer, manufacturer, and distributor of breast implants and medical devices for the global aesthetics industry, announced the micro-textured anatomical breast implant LUNA XT. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
• In May 2021, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions launched its next generation of breast implants, PERLE(TM).
• In January 2021, Mentor Worldwide LLC, a part of the Johnson & Johnson Medical Devices Companies received the US Food and Drug Administration (FDA) approval for the MENTOR(R) MemoryGel BOOST(TM) Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

Key takeaways from the Breast Implants market report study

• Market size analysis for current breast implants market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the breast implants market
• Various opportunities available for the other competitors in the breast implants market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current breast implant market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for breast implant market growth in the coming future?

Target audience who can be benefited from this Breast Implants market report study

• Breast implant providers
• Research organizations and consulting companies
• Breast Implant related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in breast implants
• Various end-users who want to know more about the breast implant market and the latest developments in the breast implant market

Frequently Asked Questions for the Breast Implants Market:

1. What are breast implants?

• The breast implants are prostheses (artificial devices) that are surgically inserted in the breast to change the shape, size, and contour of a person's breast. These implants are generally used for restoring a natural breast appearance following a mastectomy, to correct congenital defects and deformities of the chest wall, or, cosmetically, to enhance the look of the breast through breast augmentation surgery.

2. What is the market for breast implants?

• The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030.

3. What are the drivers for the breast implants market?

• The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the breast implants market?

• Some of the major market players operating in the breast implants market include Johnson & Johnson Services, Inc., HansBioMed, AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

5. Which region has the highest share in the breast implant market?

• Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, which are the major key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.